The San Diego Union-TribuneLungs make platelets, store blood stem cells: StudyThe San Diego Union-TribuneAfter discovering this process, the researchers looked for more signs of blood cells residing in the lungs. They found progenitor cells that turn i… Continue reading
Miami’s Community NewspapersThe Amazing Power of Stem CellsMiami’s Community NewspapersTwo days ago, I read a letter from my colleagues at the American Association of Pain Management Physicians, which reported that as of July 2016 (in the state of Oreg… Continue reading
Immunotherapy Making Its Mark on Head and Neck CancerTargeted OncologyFollowing the approval of 2 immunotherapy agents, pembrolizumab (Keytruda) and nivolumab (Opdivo) for the treatment of patients with head and neck cancer (HNC) over the last 6 months… Continue reading
|
BASF Licenses CRISPR/Cas9 From Broad Institute for Ag-Bio, Industrial Microbe Applications
GenomeWeb NEW YORK (GenomeWeb) – BASF announced it has reached a non-exclusive, worldwide licensing agreement with the Broad Institute for CRISPR/Cas9 genome editing in ag-bio and industrial applications. “We are eager to see the new ways it will augment … |
OncLive |
Dr. Slovin on the Role of Immunotherapy for Prostate Cancer
OncLive The FDA approval of sipuleucel-T (Provenge) represented the first successful immunotherapy for a solid tumor that showed a survival benefit. All approaches that have been done subsequently are attempting to look at other ways of using the body’s immune … |
Life Science Leader Magazine |
Cross-Lab Data Collaborations – The Future Of Immunotherapy?
Life Science Leader Magazine In the field of immunotherapy, a handful of Big Pharma companies have been racing to achieve first or second line approval of their own checkpoint inhibitors in a small set of indications, including nonsmall cell lung cancer and bladder cancer … |
|
Phase 1/2 trial of gene therapy treatment for X-linked retinitis pigmentosa begins
Healio The gene therapy, AAV-XLRPGR, uses adeno-associated virus to deliver a codon-optimized copy of the retinitis pigmentosa GTPase regulator gene into the cells of the eye, the release said. “The current trial is a multicenter open-label, dose-escalation … |